€2.9 Million Investment from the Companisto Business Angel Network and Product Sell-Out Following Strong Media Coverage for PerioTrap

The biotech startup PerioTrap has successfully closed the first tranche of its Pre-Series A financing round via the digital business angel network Companisto. A total of €2.9 million was invested in the company. bmp Ventures participated in the round through the IBG funds with a €1 million co-investment. The round will remain open for additional tranches until May 2026.
PerioTrap is a spin-off of the Fraunhofer-Gesellschaft and is developing a novel therapeutic approach to treat periodontal disease. Its selective active ingredient specifically targets key plaque-forming bacteria while preserving the healthy oral microbiome.

Dominik Malter, Investment Manager and Program Manager at Fraunhofer Venture, commented:
“Seven years ago, we set out to take the long journey from a Fraunhofer laboratory to a market-ready end-consumer product through a spin-off. Thanks to an outstanding founding team and strong support from our investor base, we have now reached a major milestone and brought a true innovation to market.”

Following the official close of the Companisto financing round in early January 2026, PerioTrap continued to receive numerous investment inquiries driven by increased public visibility. To accommodate the strong demand, the company opened a short additional investment window for the Companisto Business Angel Network.
One driver of this demand was significant media coverage. A press release issued by the Fraunhofer-Gesellschaft about PerioTrap’s technology generated widespread national and international attention. As a result, the company’s microbiome-friendly toothpaste sold out within 12 hours.

Nicky Hughes, Investment Director at Companisto, said:
“The financing round demonstrated that PerioTrap has generated broad and sustained interest among our business angels. The one-time additional investment opportunity for the Companisto Business Angel Network enabled us to meet this strong demand and further strengthen the round. Beyond the investment itself, our network will continue to support the company with expertise and connections as it scales. This was already evident during the soft launch, where members of the Companisto network actively supported the market introduction.”

Pierre Tangermann, CEO of PerioTrap, added:
“The strong response to the financing round highlights investor confidence in both our technological approach and our equity story. We deliberately chose a combination of experienced venture capital investors and an active business angel network in order to effectively combine market access, scaling capabilities, and entrepreneurial sparring.”

Andreas van Bon, Partner at bmp Ventures, commented:
“We are pleased that PerioTrap has successfully raised the capital required for its next development phase and broader market entry, while also strengthening the Halle (Saale) location with the support of the IBG funds.”

With the capital raised from the business angel network, PerioTrap plans to execute its next growth steps, including expanding its sales activities internationally and advancing its product pipeline.

About PerioTrap
PerioTrap is a biotech company developing a selective therapeutic approach that blocks the virulence of periodontal pathogens without harming the oral microbiome. The company develops active ingredients that specifically inhibit the pathogenic mechanisms of P. gingivalis. This approach forms the basis for modern preventive and oral care products designed to modulate rather than eliminate the oral microbiome.

About bmp Ventures
bmp Ventures is one of the most experienced venture capital investors in Germany, with a track record of more than 250 investments across nearly all technology segments, the majority of which are in the early stage. In addition to direct investments, bmp has also managed venture capital funds for the KfW Banking Group and DEG – Deutsche Investitions- und Entwicklungsgesellschaft. Currently, bmp manages the IBG funds in Saxony-Anhalt and employs around 20 people at its offices in Berlin and Magdeburg.

About the IBG Funds
The IBG Funds, based in Magdeburg, are the venture capital funds of the State of Saxony-Anhalt. They provide equity financing to young, innovative technology companies with above-average growth potential that are headquartered in Saxony-Anhalt. At the end of 2023, the new venture capital fund RKF IV was launched with a total volume of €63 million. It is financed by the State of Saxony-Anhalt and the European Union and invests in startups in the seed, early-stage, and growth phases. The IBG Funds are managed by bmp Ventures AG.

About Companisto
Companisto is the largest business angel network in the DACH region, with more than 6,350 business angels, and serves as a leading partner for financing high-growth startups. With over €324.3 million invested, Companisto has been one of the most active venture investors in the German-speaking region for more than a decade.

Startups financed through the network include, among others, AMERIA AG, which has raised more than €50 million in total investment through the Companisto network, and DiaMonTech AG, which secured over €8 million in a Companisto-led follow-on financing round together with Samsung Next.

Startups benefit from a structured, fully digital investment process, access to a broad network of experienced business angels, and direct access to capital—without lengthy investor searches. Companisto acts as a long-term financing partner, supporting both early-stage rounds and larger follow-on financings together with angels and international co-investors.

The goal is to sustainably strengthen innovative companies through capital, expertise, and entrepreneurial support.

Press Contact

Companisto
Sophie Schultheiss
Tel.: +49 30 208 484 957
presse@companisto.com

bmp Ventures AG
Josephine Gantze
Marketing & Events
Tel.: +49 391 5328 140
jgantze@bmp.com